WX6 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Diversified Recurring IncomeNHI’s dual revenue model—long‑term lease income plus interest from mortgage/financing—provides recurring cash flows from contractual sources. That structural mix smooths short‑term volatility, supports predictable distributions and gives flexibility to shift between property ownership and credit investments over months.
Strong Cash GenerationFCF tracking ~92% of net income indicates underlying earnings are largely cash‑backed, strengthening dividend coverage and funding for capex or debt service. Consistent operating cash flow improves resilience to cyclical occupancy swings and supports deleveraging or targeted reinvestments over the next several quarters.
Ample Liquidity And Capital Recycling PlanSubstantial liquidity combined with the $560M portfolio sale enables proactive balance sheet management. Management’s plan to reduce leverage and redeploy into higher‑yield SHOP assets gives strategic optionality to refinance maturities, pursue accretive investments and manage payout stability across the medium term.
Bears Say
Elevated Leverage & MaturitiesReported leverage near the upper end of policy and upcoming $225M maturities create refinancing and timing risk. If redeployment of sale proceeds or capital markets access is delayed, interest costs and refinancing terms could constrain cash available for growth or distributions and limit strategic flexibility over the next 2–6 months.
Tenant Concentration & Transition RiskNHI historically had a large tenant/shareholder relationship with NHC; selling that leased portfolio reduces exposure but removes contracted cash flow and requires successful redeployment. Execution, timing and tax‑deferral uncertainties around the transaction introduce earnings and governance risk during the portfolio shift.
Margin Volatility And Legacy Operational PocketsLocalized census declines, delayed CapEx and swings in gross margin signal inconsistent operating performance in parts of the portfolio. Combined with higher G&A and tighter acquisition yields, this volatility makes sustained FAD and margin expansion less certain and complicates reliable distribution planning over coming quarters.
WX6 FAQ
What was National Health Investors’s price range in the past 12 months?
Currently, no data Available
What is National Health Investors’s market cap?
National Health Investors’s market cap is CHF2.95B.
When is National Health Investors’s upcoming earnings report date?
National Health Investors’s upcoming earnings report date is Aug 10, 2026 which is in 29 days.
How were National Health Investors’s earnings last quarter?
National Health Investors released its earnings results on May 04, 2026. The company reported $0.663 earnings per share for the quarter, missing the consensus estimate of $0.69 by -$0.027.
Is National Health Investors overvalued?
According to Wall Street analysts National Health Investors’s price is currently Undervalued.
Does National Health Investors pay dividends?
National Health Investors does not currently pay dividends.
What is National Health Investors’s EPS estimate?
National Health Investors’s EPS estimate is 0.68.
How many shares outstanding does National Health Investors have?
Currently, no data Available
What happened to National Health Investors’s price movement after its last earnings report?
National Health Investors reported an EPS of $0.663 in its last earnings report, missing expectations of $0.69. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of National Health Investors?
Currently, no hedge funds are holding shares in CH:WX6
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
National Health Investors Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
CHF68.63 (― Downside)
CHF68.63 (― Downside)
Insider Transactions
Bought Shares
Worth CHF134.8K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.04%
12-Months-Change
Fundamentals
Return on Equity
9.88%
Trailing 12-Months
Asset Growth
3.84%
Trailing 12-Months
Company Description
National Health Investors
Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets. The company facilitates this through diverse financing options, including sale-leaseback arrangements, joint ventures, and various debt instruments such as mortgage and mezzanine loans, targeting properties that cater to both essential care needs and discretionary services. NHI's broad holdings feature independent living, assisted living, and memory care facilities, as well as entrance-fee retirement communities, skilled nursing homes, medical office complexes, and specialized hospitals.
WX6 Company Deck
WX6 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed significant operational and financial momentum: strong quarter-over-quarter and year-over-year growth in key metrics (net income per share, FFO, FAD), rapid expansion and investment activity in the higher-growth SHOP platform, a robust pipeline and ample liquidity. Offsetting these positives were near-term earnings pressure and guidance impacts driven by the timing of the large NHC disposition, underperformance in a small legacy Holiday same-store pool, tighter acquisition yields, modestly higher interest and G&A, and some timing/tax uncertainty related to capital gains deferral. Management framed the NHC sale as strategic for longer-term growth while acknowledging short-term earnings and timing headwinds.View all CH:WX6 earnings summariesWX6 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$68.63
Options Prices
Currently, No data available
---









